abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

14 Nov 2006

Author:
Reuters

World's poor still deprived of drugs - activists

Poor people in developing countries are still not getting access to many life-saving medicines five years after a trade declaration that rich countries should put patients before profits, campaigners said on Tuesday...Oxfam and AIDS groups said...rich countries, particularly the United States, were bullying developing countries to impose stricter patent rules in order to preserve pharmaceutical monopolies...[An example is]...a dispute over the cancer drug Glivec, made by...Novartis...An Indian court in January rejected its patent application for Glivec, but Novartis is fighting back, arguing that the principle of intellectual property protection must be protected if innovation is to flourish.

Part of the following timelines

Oxfam says rich countries still restrict access to medicines for the poor through patent rules that preserve pharmaceutical monopolies

Novartis lawsuit (re India patent law & access to medicine)(new)

Privacy information

This site uses cookies and other web storage technologies. You can set your privacy choices below. Changes will take effect immediately.

For more information on our use of web storage, please refer to our Data Usage and Cookies Policy

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Analytics cookie

ON
OFF

When you access our website we use Google Analytics to collect information on your visit. Accepting this cookie will allow us to understand more details about your journey, and improve how we surface information. All analytics information is anonymous and we do not use it to identify you. Google provides a Google Analytics opt-out add on for all popular browsers.

Promotional cookies

ON
OFF

We share news and updates on business and human rights through third party platforms, including social media and search engines. These cookies help us to understand the performance of these promotions.

Your privacy choices for this site

This site uses cookies and other web storage technologies to enhance your experience beyond necessary core functionality.